Skip to main content
. 2024 Jun 25;10(7):571–589. doi: 10.1093/ehjqcco/qcae053

Figure 2.

Figure 2

Summary of clinical practice guidelines and recommendations on heart failure with preserved ejection fraction management. CMR, cardiovascular magnetic resonance; CPET, cardiopulmonary exercise testing; GLP-1, glucagon-like peptide-1; HFpEF, heart failure with preserved ejection fraction; MRA, mineralocorticoid receptor antagonist; NP, natriuretic peptide; RAAS, renin-angiotensin-aldosterone system; SGLT2/1, sodium-glucose co-transporter 2/1; TTE, transthoracic echocardiography.